Welcome to our dedicated page for Innovage Holding news (Ticker: INNV), a resource for investors and traders seeking the latest updates and insights on Innovage Holding stock.
InnovAge Holding Corp. reports developments tied to its Program of All-inclusive Care for the Elderly (PACE) healthcare delivery platform for frail, predominantly dual-eligible seniors. The company provides comprehensive, capitated care intended to support older adults in home and community settings while managing use of hospitals, emergency rooms, and nursing homes.
Recurring news includes fiscal-quarter results, revenue and Adjusted EBITDA guidance, census and Total Member Months metrics, center performance, investments in clinical teams, technology and quality capabilities, and interactions with policymakers around the PACE model. Company updates also cover board composition, investor presentations, conference participation, and operating execution across its PACE centers.
InnovAge (Nasdaq: INNV) appointed Jennifer Browne as President and Chief Operating Officer, effective June 8, 2026. She will oversee market operations and core support functions, focusing on execution, participant experience, and operational and compliance metrics.
Browne previously led value-based care operations at Strive Health and Optum. InnovAge’s PACE model serves about 8,050 participants across 20 centers in six states as of March 31, 2026.
InnovAge (Nasdaq: INNV) reported fiscal Q3 2026 results for the quarter ended March 31, 2026. Total revenues were $251.9M, up ~15.5% year-over-year. Adjusted EBITDA rose to $30.5M and Center-level Contribution Margin reached $61.0M. The company reported a net loss of $29.9M and ended the quarter with $95.5M cash and $43.1M short-term investments.
InnovAge raised full-year 2026 revenue guidance to $950–$975M and Adjusted EBITDA guidance to $85–$90M while keeping census guidance unchanged.
InnovAge (Nasdaq: INNV) will release its fiscal third quarter 2026 financial results on Tuesday, May 5, 2026 after market close and will host a conference call at 5:00 p.m. ET that day.
A live audio webcast will be available at the company's investor website, with a replay posted shortly after the call and available for a limited time. Phone access requires registration for a unique PIN; participants are encouraged to dial in 15 minutes early.
As of December 31, 2025, InnovAge served approximately 8,010 participants across 20 centers in six states.
InnovAge (Nasdaq: INNV) leaders, participants and partner LeadingAge Colorado met lawmakers at the Colorado State Capitol on February 5, 2026 to advocate for protecting and strengthening PACE and community-based senior care.
Participants emphasized PACE’s person-centered model, lower hospitalization and nursing home admission rates, caregiver relief, and the need for greater public awareness and supportive Medicaid and workforce policies.
InnovAge (Nasdaq: INNV) reported fiscal Q2 ended December 31, 2025 results showing revenue of $239.7M (+14.7% YoY) and net income of $11.8M versus a loss in prior-year quarter. Adjusted EBITDA was $22.2M and center-level contribution margin was $52.8M (22.0% of revenue).
The company raised fiscal 2026 revenue and Adjusted EBITDA guidance to a range of $925M–$950M and $70M–$75M, while full-year ending census guidance stayed at 7,900–8,100 members.
InnovAge (Nasdaq: INNV) announced the appointment of Pavithra Mahesh and Sean Traynor to its Board of Directors, effective January 29, 2026. The Board expands from nine to eleven directors; Mahesh joins the Quality and Compliance Committee and Traynor joins the Compensation, Nominating and Governance Committee. As of September 30, 2025, InnovAge served approximately 7,890 participants across 20 centers in six states.
InnovAge (Nasdaq: INNV) will release its fiscal second quarter 2026 financial results on Tuesday, February 3, 2026, after market close.
The company will host a conference call to review results on February 3, 2026 at 5:00 p.m. ET with a live audio webcast available at the company's investor website and a replay posted shortly after the call for a limited time. Participants can also join by phone via a registration link and are encouraged to dial in 15 minutes early.
As of September 30, 2025, InnovAge served approximately 7,890 participants across 20 centers in six states.
InnovAge (Nasdaq: INNV) announced that CEO Patrick Blair will present at the 44th Annual J.P. Morgan Healthcare Conference on Monday, Jan. 12, 2026 at 9:45 a.m. PT / 12:45 p.m. ET.
The presentation and audio will be webcast live, and the webcast link plus presentation materials will be available on InnovAge’s investor relations website. As of Sept. 30, 2025, InnovAge served approximately 7,890 participants across 20 centers in six states. InnovAge delivers PACE care for frail, predominantly dual-eligible seniors with a goal of enabling independent aging at home while reducing high-cost care utilization.
InnovAge (Nasdaq: INNV) announced a joint venture with Tampa General Hospital on Nov. 11, 2025 to expand access to PACE services across the Tampa Bay region.
The partnership aims to serve frail seniors in Hillsborough, Pasco, and Hernando counties, supporting independent living with coordinated medical, social and in-home services, often at little to no cost for dual-eligible Medicaid and Medicare participants. InnovAge Florida PACE–Tampa operates a 35,000-square-foot center and InnovAge reported serving approximately 7,890 participants across 20 centers as of Sept. 30, 2025.
InnovAge (Nasdaq: INNV) reported fiscal Q1 2026 results for the quarter ended September 30, 2025, highlighting sequential and year-over-year improvement.
Key results: Total revenue of $236.1M (+15.1% vs prior-year), net income of $7.7M (vs a $5.7M loss prior-year), adjusted EBITDA of $17.6M (vs $6.5M prior-year) and center-level contribution margin of $51.4M (+48.7% vs prior-year). Census was ~7,890 participants.
Balance sheet & guidance: Cash and short-term investments totaled $109.4M, debt was reported at $71.5M, and full-year fiscal 2026 guidance was confirmed: revenue $900M–$950M, adjusted EBITDA $56M–$65M.